Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum

被引:0
|
作者
Díaz-Cabiale, Z
Hurd, Y
Guidolin, D
Finnman, UB
Zoli, M
Agnati, LF
Vanderhaeghen, JJ
Fuxe, K
Ferré, S
机构
[1] NIDA, Behav Neurosci Branch, NIH, Intramural Res Program, Baltimore, MD 21224 USA
[2] Karolinska Inst, Dept Neurosci, Stockholm, Sweden
[3] Karolinska Hosp, Dept Clin Neurosci, S-10401 Stockholm, Sweden
[4] Univ Modena & Reggio Emilia, Dept Biomed Sci, Physiol Sect, Modena, Italy
[5] Free Univ Brussels, Fac Med, Neurophysiol Lab, Brussels, Belgium
关键词
A2A receptor; adenosine; D2; receptor; dopamine; human; striatum;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Adenosine A2A receptors (A2AR) and dopamine D2 receptors (D2R) are highly concentrated in the striatum, where they are co-localized and exert reciprocal antagonistic interactions. It has been suggested that the A2R/D2R interactions might provide a therapeutic approach for basal ganglia disorders, such as Parkinson's disease, and schizophrenia. In the present work evidence is presented for the existence of an A2AR/D2R interaction in human brain by using quantitative autoradiography. The areas analyzed were the dorsal caudate nucleus and putamen. Parallel studies were performed in rat striatal sections. The A2AR agonist CGS 21680 was found to significantly increase IC50 values of competitive inhibition curves of the D2R/D3R antagonist [I-125]iodosulpiride vs dopamine both in rat striatal and human striatal brain sections. NeuroReport 12:1831-1834 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:1831 / 1834
页数:4
相关论文
共 50 条
  • [21] Clozapine:: partial agonist at dopamine D2 receptors!
    Ninan, I
    Kulkarni, SK
    PSYCHOPHARMACOLOGY, 1998, 138 (02) : 215 - 216
  • [22] Clozapine: partial agonist at dopamine D2 receptors!
    I. Ninan
    S. K. Kulkarni
    Psychopharmacology, 1998, 138 : 215 - 216
  • [23] Mechanisms of agonist action at D2 dopamine receptors
    Roberts, DJ
    Lin, H
    Strange, PG
    MOLECULAR PHARMACOLOGY, 2004, 66 (06) : 1573 - 1579
  • [24] Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors
    Michael J Higley
    Bernardo L Sabatini
    Nature Neuroscience, 2010, 13 : 958 - 966
  • [25] Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function
    Fuxe, K
    Ferré, S
    Canals, M
    Torvinen, M
    Terasmaa, A
    Marcellino, D
    Goldberg, SR
    Staines, W
    Jacobsen, KX
    Lluis, C
    Woods, AS
    Agnati, LF
    Franco, R
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2005, 26 (2-3) : 209 - 219
  • [26] Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function
    Kjell Fuxe
    Sergi Ferré
    Meritxell Canals
    Maria Torvinen
    Anton Terasmaa
    Daniel Marcellino
    Steven R. Goldberg
    William Staines
    Kirsten X. Jacobsen
    Carmen Lluis
    Amina s. Woods
    Luigi F. Agnati
    Rafael Franco
    Journal of Molecular Neuroscience, 2005, 26 : 209 - 220
  • [27] Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
    Burris, KD
    Molski, TF
    Xu, C
    Ryan, E
    Tottori, K
    Kikuchi, T
    Yocca, FD
    Molinoff, PB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01): : 381 - 389
  • [28] Functional uncoupling of adenosine A2A receptors and reduced response to caffeine in mice lacking dopamine D2 receptors
    Zahniser, NR
    Simosky, JK
    Mayfield, RD
    Negri, CA
    Hanania, T
    Larson, GA
    Kelly, MA
    Grandy, DK
    Rubinstein, M
    Low, MJ
    Fredholm, BB
    JOURNAL OF NEUROSCIENCE, 2000, 20 (16): : 5949 - 5957
  • [29] Dopamine D2 receptors in the ventral striatum in major depression
    Schneier, FR
    Martinez, D
    Abi-Dargham, A
    Talbot, PS
    Huang, H
    Hwang, DR
    Liebowitz, MR
    Laruelle, M
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 109S - 109S
  • [30] Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum
    Prasad, Kavya
    de Vries, Erik F. J.
    Sijbesma, Jurgen W. A.
    Garcia-Varela, Lara
    Vazquez-Matias, Daniel A.
    Moraga-Amaro, Rodrigo
    Willemsen, Antoon T. M.
    Dierckx, Rudi A. J. O.
    van Waarde, Aren
    MOLECULAR PHARMACEUTICS, 2022, 19 (08) : 2992 - 3001